{
  "id": 12632333,
  "title": "Rivercell Launches With $25 Million to Build Data Platforms and AI Models That Predict How Human Cells Respond to Treatment",
  "url": "https://urgent.news/2026/10/07/rivercell-launches-with-25-million-to-build-data-platforms-and-ai",
  "topic": "ai",
  "section": "AI",
  "published": "2026-10-07T13:10:01.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/pmn/business-wire-news-releases-pmn/rivercell-launches-with-25-million-to-build-data-platforms-and-ai-models-that-predict-how-human-cells-respond-to-treatment"
  },
  "original_language": "en",
  "account": null,
  "summary": "Rivercell, a Paris-based biotechnology and AI company, has secured a $25 million seed round to develop data platforms and AI models that predict how human cells respond to treatment. The funding, led by HV, will be used to expand Rivercell's proprietary data generation platform, increase its wet lab capabilities in Paris, and launch its AI Virtual Cell program. The company's world model, which is indication-agnostic, learns the underlying rules of how human cells respond to drugs and genetic changes, making it a potential driver of groundbreaking discoveries across various cell behaviors that lead to disease.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}